Research Article

Association of IL-6 Polymorphism -174G/C and Metabolic Syndrome in Hypertensive Patients

Table 1

Clinical and biochemical characteristics of MetS+ and MetS populations.

Total Population MetS+MetS
314298

Age (years)57.3 ± 10.157.8 ± 9.456.6 ± 10NS
Gender (% men)34.238.130.7<0.05
BMI29.4 ± 5.231.4 ± 4.927.2 ± 4.7<0.01
SBP (mmhg)136.2 ± 19.7138.3 ± 18.5133.9 ± 20.6<0.01
DBP (mmhg)84.7 ± 11.585.7 ± 11.283.7 ± 11.1<0.05
Waist (cm)95.9 ± 12.2101.1 ± 10.590.3 ± 11.5<0.01
Glu (mg/dL)103.3 ± 42.9115.1 ± 45.690.3 ± 35.4 <0.05
Chol (mg/dL)211.2 ± 41.2213.1 ± 44.2209.1 ± 37.6NS
LDL-C (mg/dL)123.6 ± 35.8124.5 ± 37.0122.7 ± 34.4NS
HDL-C (mg/dL)57.4 ± 15.652.3 ± 13.163.0 ± 16.2<0.01
VLDL-C (mg/dL)28.3 ± 13.133.7 ± 13.222.7 ± 10.6<0.01
TG (mg/dL)152.9 ± 95.0186.6 ± 107.4115.6 ± 60.0<0.05
GFR (mL/min)79.2 ± 24.983.6 ± 25.974.4 ± 28.8<0.01
Total leukocytes (mm3)6250 ± 18876520 ± 18285953 ± 1910<0.01
CRP (mg/dL)0.57 ± 0.690.68 ± 0.730.44 ± 0.62<0.01
APO-A (mg/dL)141.9 ± 25.4136.1 ± 23.3146.1 ± 26.2<0.01

BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; Glu: glucose; Chol: Total cholesterol; LDL-C: Low density lipoprotein cholesterol; HDL-C: High density lipoprotein cholesterol; VLDL-C: Very low density lipoprotein cholesterol; TG: Triglycerides; GFR: Glomerular filtration rate; CRP: C-reactive protein; APO-A: Apolipoprotein A. MetS+ versus MetS.